OBJECTIVE: To examine return-to-play (RTP) practice differences between high school and collegiate athletes, as well as the stability (ie, year-by-year) in these practices over a 5-year period. We hypothesized that similar protocols for treatment will be comparable across competition levels and that these practices will vary year-to-year. DESIGN: Prospective cohort study. SETTING: Nine high schools and 4 National Collegiate Athletic Association Division III colleges in Southeastern Wisconsin. PARTICIPANTS AND INDEPENDENT VARIABLES: Two-hundred seventy-three (N = 273) athletes with sport-related concussions (SRCs). Independent predictors included competition level (high school, n = 88 vs collegiate, n = 185) and year-of-injury. OUTCOME MEASURES: Athletes were evaluated prospectively for differences in symptom duration, symptom free waiting period (SFWP), and time to RTP, as well as longitudinal changes in management. RESULTS: High school and collegiate athletes experienced comparable median symptom duration (high school, 6.0 days, interquartile range (IQR) = 3.5-11.0; college, 6.0 days, IQR = 4.0-9.0, P = 0.95), SFWP (high school, 5.0 days, IQR = 3.0-8.0; college, 5.0 days, IQR = 3.0-7.0, P = 0.12), and total time to RTP (high school, 10.5 days, IQR = 7.0-16.0; college, 11.0 days, IQR = 8.0-14.0 days, P = 0.94). A Cox regression analysis revealed a nonsignificant trend toward longer SFWPs in high school athletes (P = 0.055; hazard ratio = 1.347, confidence interval = 0.99-1.83). Among football players, SFWPs in 2017 (Median = 3.5 days, IQR = 1.5-5.0 days) were significantly longer than those in 2014 (Median = 5.0 days, IQR = 4.0-8.5 days, P = 0.029) after correction for multiple comparisons. CONCLUSION: Similar postinjury and RTP management practices were observed at the high school and collegiate levels after SRCs. Symptom duration and time from injury to unrestricted RTP were comparable, although high school athletes may have longer SFWPs.
OBJECTIVE: To examine return-to-play (RTP) practice differences between high school and collegiate athletes, as well as the stability (ie, year-by-year) in these practices over a 5-year period. We hypothesized that similar protocols for treatment will be comparable across competition levels and that these practices will vary year-to-year. DESIGN: Prospective cohort study. SETTING: Nine high schools and 4 National Collegiate Athletic Association Division III colleges in Southeastern Wisconsin. PARTICIPANTS AND INDEPENDENT VARIABLES: Two-hundred seventy-three (N = 273) athletes with sport-related concussions (SRCs). Independent predictors included competition level (high school, n = 88 vs collegiate, n = 185) and year-of-injury. OUTCOME MEASURES: Athletes were evaluated prospectively for differences in symptom duration, symptom free waiting period (SFWP), and time to RTP, as well as longitudinal changes in management. RESULTS: High school and collegiate athletes experienced comparable median symptom duration (high school, 6.0 days, interquartile range (IQR) = 3.5-11.0; college, 6.0 days, IQR = 4.0-9.0, P = 0.95), SFWP (high school, 5.0 days, IQR = 3.0-8.0; college, 5.0 days, IQR = 3.0-7.0, P = 0.12), and total time to RTP (high school, 10.5 days, IQR = 7.0-16.0; college, 11.0 days, IQR = 8.0-14.0 days, P = 0.94). A Cox regression analysis revealed a nonsignificant trend toward longer SFWPs in high school athletes (P = 0.055; hazard ratio = 1.347, confidence interval = 0.99-1.83). Among football players, SFWPs in 2017 (Median = 3.5 days, IQR = 1.5-5.0 days) were significantly longer than those in 2014 (Median = 5.0 days, IQR = 4.0-8.5 days, P = 0.029) after correction for multiple comparisons. CONCLUSION: Similar postinjury and RTP management practices were observed at the high school and collegiate levels after SRCs. Symptom duration and time from injury to unrestricted RTP were comparable, although high school athletes may have longer SFWPs.
Authors: M Aubry; R Cantu; J Dvorak; T Graf-Baumann; K Johnston; J Kelly; M Lovell; P McCrory; W Meeuwisse; P Schamasch Journal: Br J Sports Med Date: 2002-02 Impact factor: 13.800
Authors: Juliet K Haarbauer-Krupa; R Dawn Comstock; Michael Lionbarger; Shawn Hirsch; Andrew Kavee; Brooks Lowe Journal: Brain Inj Date: 2018-06-28 Impact factor: 2.311
Authors: Michael McCrea; Kevin Guskiewicz; Christopher Randolph; William B Barr; Thomas A Hammeke; Stephen W Marshall; Matthew R Powell; Kwang Woo Ahn; Yanzhi Wang; James P Kelly Journal: J Int Neuropsychol Soc Date: 2012-10-12 Impact factor: 2.892
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Bob Cantu; Jirí Dvorák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard G Ellenbogen; Kevin Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: Br J Sports Med Date: 2013-04 Impact factor: 13.800
Authors: Christopher C Giza; Jeffrey S Kutcher; Stephen Ashwal; Jeffrey Barth; Thomas S D Getchius; Gerard A Gioia; Gary S Gronseth; Kevin Guskiewicz; Steven Mandel; Geoffrey Manley; Douglas B McKeag; David J Thurman; Ross Zafonte Journal: Neurology Date: 2013-03-18 Impact factor: 9.910
Authors: Andrew W Kuhn; Scott L Zuckerman; Aaron M Yengo-Kahn; Zachary Y Kerr; Douglas J Totten; Kolin E Rubel; Allen K Sills; Gary S Solomon Journal: Neurosurgery Date: 2017-09-01 Impact factor: 4.654
Authors: H L Laurer; F M Bareyre; V M Lee; J Q Trojanowski; L Longhi; R Hoover; K E Saatman; R Raghupathi; S Hoshino; M S Grady; T K McIntosh Journal: J Neurosurg Date: 2001-11 Impact factor: 5.115
Authors: Michael McCrea; Kevin M Guskiewicz; Stephen W Marshall; William Barr; Christopher Randolph; Robert C Cantu; James A Onate; Jingzhen Yang; James P Kelly Journal: JAMA Date: 2003-11-19 Impact factor: 56.272